Basics of Compounding for Hazardous Drugs, Part 1: An Introduction

Author(s):  Allen Loyd V Jr

Issue:  Sep/Oct 2006 - Dermatology
View All Articles in Issue

Abstract:  National Institute of Occupational Safety and Health Publication No. 2004–165, Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings, was published in 2004 to increase the awareness of healthcare workers and other professionals about the health risks of working with hazardous drugs and to provide measures for protecting their health. The health risks to employees who prepare or administer hazardous drugs in the workplace is influenced by many factors, and each compounding facility is responsible for developing its own list of hazardous drugs and for creating standard operating procedures to reduce risks as much as possible for employees. To provide employees with the greatest protection, employers should (1) implement necessary administrative and engineering controls, and (2) assure that the workers use sound procedures and proper protective equipment for handling hazardous drugs.

Related Keywords: USP, hazardous drugs, cytotoxic drugs, chemotherapy, workplace safety

Related Categories: BUSINESS, LEGAL, SUPPORT, HAZARDOUS DRUGS

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=2450

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products